Patents Represented by Attorney Francis X. Murphy
  • Patent number: 4230880
    Abstract: The novel stereoselective and regioselective alkali metal borohydride reduction of 2,5-diketogluconic acid, alkyl esters or salts thereof to form 2-ketogluconic acid together with lesser amounts of 2-ketogluconic acid is disclosed. The 2-ketogluconic acid is readily converted to ascorbic acid.
    Type: Grant
    Filed: February 16, 1979
    Date of Patent: October 28, 1980
    Assignee: Pfizer Inc.
    Inventor: Glenn C. Andrews
  • Patent number: 4226875
    Abstract: Novel spiro-oxazolidinediones useful as aldose reductase inhibitors and as therapeutic agents for the treatment of chronic diabetic complications are disclosed. Pharmaceutical compositions containing the novel compounds and a method of treating chronic diabetic complications are also disclosed.
    Type: Grant
    Filed: April 2, 1979
    Date of Patent: October 7, 1980
    Assignee: Pfizer Inc.
    Inventor: Rodney C. Schnur
  • Patent number: 4219483
    Abstract: Novel 2,3,6-substituted-4-pyrones having activity as prostaglandin antagonists are disclosed, together with intermediates useful for the preparation thereof. Methods of using the compounds of this invention as prostaglandin antagonists are described.
    Type: Grant
    Filed: September 11, 1978
    Date of Patent: August 26, 1980
    Assignee: Pfizer Inc.
    Inventors: Donald E. Kuhla, Jacob J. Plattner
  • Patent number: 4212988
    Abstract: 2,5-Diketogluconic acid, alkyl esters or salts thereof, are reduced by an amine-borane to 2-ketogulonic acid, an intermediate for the preparation of ascorbic acid.
    Type: Grant
    Filed: March 26, 1979
    Date of Patent: July 15, 1980
    Assignee: Pfizer Inc.
    Inventor: Glenn C. Andrews
  • Patent number: 4210663
    Abstract: Novel halogen-substituted benzopyran-4-carboxylic acids, benzothiopyran-4-carboxylic acids and derivatives thereof useful as aldose reductase inhibitors and as therapeutic agents for the treatment of chronic diabetic complications are disclosed. Specific compounds disclosed include 6-phenyl-8-chloro-3,4-dihydro-2H-1-benzopyran-4-carboxylic acid, 6,7-dichloro-3,4-dihydrobenzothiopyran-4-carboxylic acid, 6-chloro-8-methyl-3,4-dihydro-2H-1-benzopyran-4-carboxylic acid, 6,8-dichloro-3,4-dihydro-2H-1-benzopyran-4-carboxylic acid, 6-fluoro-3,4-dihydro-2H-1-benzopyran-4-carboxylic acid, 6-chloro-3,4-dihydro-2H-1-benzopyran-4-carboxylic acid, 6-chloro-dihydro-2H-naphtho[1,2-b]pyran-4-carboxylic acid, 6-chloro-3,4-dihydro-2H-1-benzothiopyran-4-carboxylic acid and 6-chloro-3,4-dihydro-2H-1-benzopyran-4-acetic acid. Also disclosed are pharmaceutical compositions containing the novel compounds and a method of using the novel compounds for the treatment of chronic diabetic complications.
    Type: Grant
    Filed: November 8, 1978
    Date of Patent: July 1, 1980
    Assignee: Pfizer Inc.
    Inventor: John L. Belletire
  • Patent number: 4205445
    Abstract: A novel dental surveyor for use in analyzing and working upon dental models is disclosed. The surveyor contains one or more vertical tools, such as marking tools, wax relieving tools and tapered tools. Rotation of a spindle received within a sleeve about its longitudinal axis, combined with horizontal sliding of tool housings upon tool support means attached to said spindle, allows the tools to contact the entire surface of a dental model while always remaining oriented in the vertical direction. The surveyor may also be equipped with e.g. a grinding or drilling tool and means for locking such a tool against horizontal movement while in use.
    Type: Grant
    Filed: July 24, 1978
    Date of Patent: June 3, 1980
    Assignee: Howmedica, Inc.
    Inventor: Chieh-Fu Tzeng
  • Patent number: 4200642
    Abstract: Novel spiro-oxazolidindiones useful as aldose reductase inhibitors and as therapeutic agents for the treatment of chronic diabetic complications are disclosed. Pharmaceutical compositions containing the novel compounds and a method of treating chronic diabetic complications are also disclosed.
    Type: Grant
    Filed: August 21, 1978
    Date of Patent: April 29, 1980
    Assignee: Pfizer Inc.
    Inventor: Rodney C. Schnur
  • Patent number: 4193996
    Abstract: Novel spiro-quinolone hydantoin derivatives useful as aldose reductase inhibitors and as therapeutic agents for the treatment of chronic diabetic complications are disclosed. Pharmaceutical compositions containing the novel compounds and a method of treating chronic diabetic complications are also disclosed. Preferred compounds include spiro[2,3-dihydro-1H,5H-benzo[ij]quinolizin[1,4']imidazolidin]-2',5,5.dbd. -trione and 10-chloro-spiro[2,3-dihydro-1H,5H-benzo[ij]quinolizin[1,4']imidazolidin]-2 ',5,5'-trione.
    Type: Grant
    Filed: April 4, 1979
    Date of Patent: March 18, 1980
    Assignee: Pfizer Inc.
    Inventor: Rodney C. Schnur
  • Patent number: 4181258
    Abstract: A sprayer for repairing a refractory lining comprising a vertical, axially movable and rotatable nozzle pipe; a stationary housing disposed about a portion of the pipe; a pair of parallel, connected turntables rotatably supported within the housing axial with and through which the pipe freely passes; motor-driven wheels mounted on the undersides of the turntables for supporting the pipe and driving it in either axial direction relative to the housing; and the combination of a first gear mounted on the upperside of one turntable coaxial with and through which the pipe freely passes intermeshed with a second, motor-driven gear mounted on the housing for rotating the pipe together with the wheels.
    Type: Grant
    Filed: March 21, 1978
    Date of Patent: January 1, 1980
    Assignee: Quigley Company, Inc.
    Inventor: Minoru Ogawa
  • Patent number: 4180511
    Abstract: An improved process for the preparation of ascorbic acid and erythorbic acid is disclosed, the improvement comprising the removal of borate impurities from a 2-ketogulonate and a 2-ketogluconate prior to formation of the desired acids by base catalyzed cyclization.
    Type: Grant
    Filed: September 22, 1978
    Date of Patent: December 25, 1979
    Assignee: Pfizer Inc.
    Inventor: Thomas C. Crawford
  • Patent number: 4180654
    Abstract: Derivatives of oleandomycin, erythromycin A and B, erythromycylamine and erythromycin carbonate, having at the 4"-position an acylamido group, their preparation and use as antibacterial agents are described.
    Type: Grant
    Filed: August 29, 1978
    Date of Patent: December 25, 1979
    Assignee: Pfizer Inc.
    Inventor: Frank C. Sciavolino
  • Patent number: 4176185
    Abstract: Novel spiro-quinolylhydantoin derivatives useful as aldose reductase inhibitors and as therapeutic agents for the treatment of chronic diabetic complications are disclosed. Preferred compounds include spiro[imidazolidin-4,4'-pyrano[3,2-h]quinolin]-2,5-dione and spiro[imidazolidin-4,4'-pyrano[2,3-f]quinolin]-2,5-dione.
    Type: Grant
    Filed: January 22, 1979
    Date of Patent: November 27, 1979
    Assignee: Pfizer Inc.
    Inventor: Rodney C. Schnur
  • Patent number: 4176196
    Abstract: Novel hypoglycemic agents comprising 3-hydroxy-3-arylcyclohexane-1-acetic acid, 3-arylcyclohexene-1-acetic acids and derivatives thereof are disclosed.
    Type: Grant
    Filed: November 4, 1977
    Date of Patent: November 27, 1979
    Assignee: Pfizer Inc.
    Inventor: Lawrence S. Melvin, Jr.
  • Patent number: 4175193
    Abstract: The reaction of isatoic anhydrides with malononitrile in a reaction-inert solvent in the presence of a base to produce 2-amino-3-cyano-4-hydroxyquinolines and 2-amino-.alpha.,.alpha.-dicyanoacetophenones which are then hydrolyzed and decarboxylated under acid or base conditions to produce 2-amino-4-hydroxyquinolines, useful as intermediates for preparation of 1-oxo-1H-6-alkoxypyrimido[1,2-a]quinoline-2-carboxylic acids and esters of value as antiallergy agents.
    Type: Grant
    Filed: March 27, 1978
    Date of Patent: November 20, 1979
    Assignee: Pfizer Inc.
    Inventor: Saul B. Kadin
  • Patent number: 4166901
    Abstract: Derivatives of oleandomycin, its 11-monoalkanoyl, 2-monoalkanoyl and 11,2'-dialkanoyl esters having at the 4"-position an amino group substituted with --C(.dbd.O)--C(.dbd.O)--R.sub.3 or --C(.dbd.S)--C(.dbd.O)--R.sub.3 wherein R.sub.3 is alkyl having from one to four carbon atoms, phenyl, substituted phenyl, or a heterocyclyl group, their preparation and use as antibacterial agents is described.
    Type: Grant
    Filed: October 23, 1978
    Date of Patent: September 4, 1979
    Assignee: Pfizer Inc.
    Inventor: Gene M. Bright
  • Patent number: 4159990
    Abstract: The novel stereoselective and regioselective alkali metal borohydride reduction of 2,5-diketogluconic acid, alkyl esters or salts thereof to form 2-ketogulonic acid together with lesser amounts of 2-ketogluconic acid is disclosed. The 2-ketogulonic acid is readily converted to ascorbic acid.
    Type: Grant
    Filed: October 20, 1977
    Date of Patent: July 3, 1979
    Assignee: Pfizer Inc.
    Inventor: Glenn C. Andrews
  • Patent number: 4150220
    Abstract: A series of 4"-deoxy-4"-amino-erythromycin A antibacterial agents and their preparation from erythromycin A via 4"-deoxy-4"-oxo-erythromycin A intermediates.
    Type: Grant
    Filed: December 1, 1977
    Date of Patent: April 17, 1979
    Assignee: Pfizer Inc.
    Inventor: Frank C. Sciavolino
  • Patent number: 4147872
    Abstract: Azacycloalkanes, and derivatives thereof, including unsaturated analogs, each of which has at the 3-position a 2-hydroxy-4-substituted phenyl group wherein the 4-position substituent is alkyl which can have an oxygen atom as part of the chain, or aralkyl which can have an oxygen atom as part of the alkyl chain, their use for pharmacological and medicinal purposes, intermediates therefor and processes for their preparation.
    Type: Grant
    Filed: September 13, 1977
    Date of Patent: April 3, 1979
    Assignee: Pfizer Inc.
    Inventors: Thomas H. Althuis, Charles A. Harbert, Michael R. Johnson, Lawrence S. Melvin, Jr.
  • Patent number: 4140848
    Abstract: Derivatives of oleandomycin, its 11-monoalkanoyl and 11,2'-dialkanoyl esters having at the 4"-position an amino group substituted with a group having the formula --(CH.sub.2).sub.n --Z--R wherein n is an integer from 2 to 4 when Z is O, S, SO, SO.sub.2 or NH, and n is an integer from 1 to 4 when Z is CO or CHOH, and R is a phenyl, substituted phenyl or a heterocyclyl group, their preparation, and use as antibacterial agents is described.
    Type: Grant
    Filed: January 17, 1978
    Date of Patent: February 20, 1979
    Assignee: Pfizer Inc.
    Inventor: Robert F. Myers
  • Patent number: 4136253
    Abstract: A series of 4"-deoxy-4"-sulfonylamino-oleandomycin antibacterial agents and their preparation from semi-synthetic 4"-deoxy-4"-amino-oleandomycin intermediates.
    Type: Grant
    Filed: March 6, 1978
    Date of Patent: January 23, 1979
    Assignee: Pfizer Inc.
    Inventor: Arthur A. Nagel